JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Pathology Section DOI : 10.7860/JCDR/2019/39712.12708
Year : 2019 | Month : Mar | Volume : 13 | Issue : 03 Full Version Page : EC15 - EC18

A Histo-Morphological Study of Changes in Neoadjuvant Chemotherapy in Breast Malignancies

Cheryl Sarah Philipose1, T Umashankar2, Rohan Chandra Gatty3

1 Assistant Professor, Department of Pathology, Kasturba Medical College, Mangalore, Karnataka, India.
2 Professor, Department of Pathology, Father Muller Medical College, Mangalore, Karnataka, India.
3 Associate Professor, Department of Surgical Oncology, Father Muller Medical College, Mangalore, Karnataka, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Cheryl Sarah Philipose, “Malabar-Hill”, Above CSB ATM, Falnir, Mangalore-575001, Karnataka, India.
E-mail: cherylphilipose@yahoo.com
Abstract

Introduction

The administration of systemic chemotherapy in order to shrink the size of the tumour before surgical redivtion is termed as Neoadjuvant Chemotherapy (NACT) and has been shown to improve the overall disease free survival. It also helps in downstaging the tumour and monitoring treatment efficacy.

Aim

To study the histo-morphological features following NACT in breast malignancies.

Materials and Methods

The present study was carried out in a tertiary care hospital in Southern India between November 2013 and December 2014. Twenty two cases of breast carcinomas were analysed and the histo-morphological alterations were studied.

Results

Twenty two cases of breast carcinomas were studied. The age group ranged from 27 to 70 years. Five cases showed marked response following NACT while 17 cases showed poor response. The nuclear alterations were pyknosis (n=16), karyorrhexis (n=14) and karyolysis (n=14). The cytoplasmic alterations included vacuolation and foamy cell change. The stromal alterations included lymphoplasmacytic infiltrate (n=19), hyalinisation (n=17), collection of foamy macrophages (n=5), fibrosis (n=5), haemosiderin laden macrophages (n=5), giant cell formation (n=5).

Conclusion

As NACT is increasingly becoming the standard of care for patients with breast malignancies, Pathologists need to be aware of the myriad of histo-morphological features that may be seen in specimens following radical surgery and be able to predict the probable chemoresponsiveness to NACT. In the present study, the histo-morphological features included nuclear, cytoplasmic and stromal alterations.

Keywords

Introduction

The administration of systemic chemotherapy in order to shrink the size of the tumour before surgical resection is termed as NACT. It was initially described for advanced inoperable carcinomas, but is now being increasingly used for operable cancers as well. The idea is to improve surgical outcome, reduce risk of distant metastasis, achieve tumour shrinkage, downstage the disease, evaluate the effectiveness of systemic therapy and prolong overall disease free survival. Histopathological tumour regression is considered as the gold standard for the assessment of treatment response in many solid malignancies [1]. The distinctive advantage of Neoadjuvant Therapy (NAT) in breast carcinoma is the ability of the patients to undergo breast conserving surgeries and achieve negative axillary lymph node status.

Studies have shown that the patients who do not have any evidence of residual tumour, post NACT, correspond with longer disease free and overall survival [2]. The pathologists are increasingly encountering breast carcinoma specimens which have received NACT due to current trends in breast cancer management [3]. Moreover, standard guidelines for assessment of specimens following NACT has not been clearly described [4]. In the present study, we aim to study various histo-morphological features in breast carcinomas following NACT and evaluate the utility of the Chevallier grading system in assessment of histological response.

Materials and Methods

The present study was a prospective study that included 22 patients who had been diagnosed with breast carcinomas and had undergone NACT who were referred to a tertiary care hospital in Southern India between November 2013 and December 2014. The Institutional ethics committee clearance was obtained prior to commencement of study. All patients with breast carcinomas who had previously received NACT followed by Modified Radical Mastectomy (MRM) having a previous biopsy diagnosis prior to NACT were included in the present study. The patients who did not received NACT, incisional biopsies, and those cases where a biopsy prior to NACT administration was unavailable were excluded from the present study.

In each case, a detailed history and clinical examination, radiological investigations and previous biopsies were recorded from the medical records of the patients. The resection specimens obtained after MRM following NACT were studied as per standard protocol. The specimens were fixed in 10% formalin, grossed and sections were taken from the lesion and the lymph nodes. The tissue bits were processed and embedded in paraffin. The paraffin sections were stained by Haematoxylin and Eosin (H&E) stain and studied under the microscope. A detailed study of the histopathological specimens following chemotherapy were evaluated for histo-morphological changes. The tumour cells were evaluated for nuclear features such as karyorrhexis, pyknosis and karyolysis. The cytoplasmic features studied included vacuolation of cytoplasm and foamy cell change. The stroma was examined for host response such as inflammatory reaction, giant cell reaction and hyalinization. The pathological response was evaluated by Chevallier grading system [5].

Pathological response grading was done as follows:

Pathological Complete Response (pCR)- No residual invasive carcinoma or DCIS in breast or lymph nodes.

Pathological Partial Response (pPR)- Presence of residual invasive carcinoma exhibiting stromal alterations.

Pathological No Response (pNR)- Little change in appearance or original carcinoma. The results thus obtained were analysed and tabulated.

Results

A total of 22 cases of breast carcinomas were included in the present study. The age of the patients ranged from 27 to 70 years (mean=49.5).

All the patients in the study presented clinically with a palpable breast lump. In the present study, both the left and the right breast were encountered with equal frequency. The most commonly affected site was the upper outer quadrant (n=5). The skin changes commonly encountered were ulceration, fungation and hyperpigmented nodule.

A previous biopsy report were available for all the cases of which a diagnosis of infiltrating ductal carcinoma was most commonly documented (n=20), followed by one case of infiltrating lobular carcinoma and infiltrating papillary carcinoma respectively.

Evaluation of ER, PR, HER2/neu status prior to NACT was documented in five cases. Majority were ER, PR positive and HER2/neu negative.

All the cases in the present study received chemotherapy and the number of cycles ranged from 3 to 11 cycles.

Residual tumour following NACT was present in 17 cases of which a grey white infiltrative growth was the most commonly encountered on gross finding (n=13), followed by two cases of fungating growth and one case of cyst and sclerosis respectively. The gross findings following NACT are depicted in [Table/Fig-1].

Nuclear features following neoadjuvant chemotherapy in breast carcinomas including karyolysis (yellow arrow), pyknosis (Black arrowhead) and karyorrhexis (Black arrow) (H&E, X400).

In the cases with pCR, the finding of sclerosis (n=5) was common.

Majority of the residual tumours were infiltrating ductal carcinomas (n=15), followed by infiltrating lobular carcinoma (n=1) and infiltrating papillary carcinoma (n=1). It was observed that there was no change in histological type after administration of NACT.

Of the cases studied, an SBR grade of 2 was noted in 13 cases whereas SBR grade of 3 was noted in four cases.

The various patterns of arrangement of residual tumour were tubules, sheets, nests, papillae, cords, trabaculae, comedo and cribriform.

Necrosis was observed in 16 cases. All of the cases showing pCR to NACT showed necrosis. Among the nuclear alterations following NACT, the most commonly encountered was pyknosis (n=16 cases). The other nuclear alteration observed were karyorrhexis (n=14) and karyolysis (n=14) [Table/Fig-1].

Vacuolation was a commonly associated cytoplasmic alteration seen in 15 cases.

The consistently found stromal alteration were lymphoplasmacytic infiltrate (n=19), followed by hyalinisation (n=17), collection of foamy macrophages (n=5), fibrosis (n=5), haemosiderin laden macrophages (n=5), giant cell formation (n=5) [Table/Fig-2,3 and 4].

Stromal alterations following neoadjuvant chemotherapy in breast carcinomas showing lymphoplasmacytic infiltrate (black arrow). (H&E, X200).

Stromal alterations following neoadjuvant chemotherapy in breast carcinomas showing sclerosis (black arrow) (H&E, X400).

Stromal alterations following neoadjuvant chemotherapy in breast carcinomas showing haemosiderin laden macrophages (black arrow) (H&E, X400).

Lymphovascular invasion was observed in 13 cases while lymph node metastasis was observed in 17 cases.

Discussion

NACT is the delivery of systemic chemotherapeutic agents prior to definitive surgery. Many studies have shown the benefits of NACT to be manifold [2]. The response to a systemic agent can be studied and a patient can be assessed accordingly. Those patients showing a pCR may have a long term disease free interval. As NACT is being increasingly adapted for treatment of early stage malignancies, Pathologists need to be aware of these varied constellation of NACT induced changes [6].

Clinical trials have shown excellent correlation between response to NAT and disease free overall survival in patients with breast carcinomas.

A total of 22 cases of breast malignancies that received NACT were analysed in the present study. In the present study, the age of the patients ranged from 27-70 years (median=49.5) similar to a study by Carey et al., [7]. The majority of the patients in their study received NACT while a proportion of cases received radiotherapy. In contrast, all the patients in the present study received only chemotherapy. According to the authors, there was no accurate and reliable response classification system, while most resorted to pCR as a tool for assessing response. They found that the revised AJCC (2003) classification was effective in assessing response. The other response systems recommended by the authors was the response used by the Milan Cancer institute and a method devised by the authors themselves in a previous study. They were of the opinion that the pCR albeit prognostic, was limited due to the small number of patients who achieved the end result [8-10].

In the present study, a thorough clinical assessment of primary breast lesion and axillary lymph nodes by physical examination was performed in each case, supplemented by relevant radiological and pathological study. A few of the researchers are of the opinion that physical examination and mammography is essential, others feel that sonography correlates best with pathological study [11].

Evaluation of tumour markers such as ER, PR and HER2/neu prior to NACT was available in five cases of which majority were ER, PR positive while all the tumours were HER2/neu negative. According to some studies, by and large the hormonal status remains the same following NACT; however some types of therapy may induce a change in the tumour marker expression [2].

Studies have shown different variables to be prognostically significant. The amount of residual tumour in specimens following NACT has been found to be an excellent prognostic indicator [6]. The number of positive lymph nodes in a surgical specimen with prior NACT and the number of chemotherapy cycles given were also independent prognostic indicators [12]. In the present study, the number of cycles of chemotherapy ranged from 3-11 in number. A pCR was seen in those cases which had received 4 or more cycles while a pNR was seen in those cases with 3 cycles of chemotherapy. Majority of the cases showed pNR following NACT.

In all of the cases showing pCR to chemotherapy, sclerosis was the most common finding. Residual tumour following pNR to NACT was noted in 16 cases. Of these, the most common gross finding was an infiltrative growth followed by fungating growth, cyst and sclerosis. Majority of the residual tumours were infiltrative ductal carcinoma with an SBR grade of 2. These findings were similar to a similar study by Sethi D et al., [6].

Necrosis was observed in 16 cases. All the cases showing pCR to NACT showed necrosis. According to some studies, histopathological measurement of tumour necrosis constituted an important prognostic variable in patients with osterosarcoma who received NACT [13]. A study done by Bonadonnna et al., [8]., has shown that following administration of NACT, cellularity of tumour mass shows significant reduction. However, this change is highly variable among different patients.

Following NACT, a constellation of histo-morphological changes were noted in the present study. Previous studies have similarly described several nuclear and cytoplasmic alteration following NACT such as nuclear enlargement, nuclear skrinkage, nuclear pyknosis, nuclear vacoulation, necrosis, cytoplasmic vacoulation and degenerative changes, loss of architecture, dyscohesion, shrinkage of tumour cells, karyorrhexis, karyolysis [5,14-16].

In the present study, the most commonly encountered nuclear alterations following NACT was pyknosis while others such as karyorrhexis and karyolysis were observed to a lesser extent. Vacuolation was the most commonly seen cytoplasmic alteration along with foamy cell change. The consistently found stromal alteration was lymphoplasmacytic infiltrate, followed by hyalinisation, collection of foamy macrophages, fibrosis, haemosiderin laden macrophages, giant cell formation. In a similar study, the authors studied stromal changes such as fibrosis, elastosis, collagenisation, hyalinisation, microcalcification, neovascularisation, lymphocytic infiltrate and giant cell reaction of which giant cell reaction significantly correlated to all types of tumour responses [5].

According to some studies, lymph node status is an important for prognosis in patients who have received NACT with patients who have achieved complete response in both breast as well as axillary nodes have been shown to have a better disease free overall survival [2].

Lymphovascular invasion was observed in 13 cases while lymph node metastasis was observed in 17 cases. Studies by Dershaw et al., concluded that NACT was a significant independent parameter for a reduced lymph node yield following an axillary dissection [11].

Limitation

The limitations of the study include small sample size and unavailability of follow-up data. Furthermore, data on clinical staging of the tumour prior to commencement of NAT as well as following NAT was unavailable.

Conclusion

Pathologists need to be aware of the myriad of histo-morphological features that may be seen in specimens following radical surgery. Sclerosis was the most common gross finding and necrosis, pyknosis, cytoplasmic vacuolation and lymphoplasmacytic infiltrate were the common histological finding in cases with pCR and in cases showing moderate and poor response to NACT.

References

[1]Sassen S, Schmalfeldt B, Avril N, Kuhn W, Busch R, Hofler H, Histopathologic assessment of tumour regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer Hum Pathol 2007 38:926-34.10.1016/j.humpath.2006.12.00817397905  [Google Scholar]  [CrossRef]  [PubMed]

[2]Sahoo S, Lester SC, Pathology of breast carcinomas after neoadjuvant chemotherapy Arch Pathol Lab Med 2009 133:633-42.  [Google Scholar]

[3]Moore GH, Schiller JE, Moore GK, Radiation-induced histopathologic changes of the breast: The effects of time Am J Surg Pathol 2004 28:47-53.10.1097/00000478-200401000-0000414707863  [Google Scholar]  [CrossRef]  [PubMed]

[4]Park CK, Jung W-H, Koo JS, Pathologic evaluation of breast cancer after neoadjuvant therapy J Pathol and Transl Med 2016 50:173-80.10.4132/jptm. 2016.02.0227068026  [Google Scholar]  [CrossRef]  [PubMed]

[5]Vasudevan D, Jayalakshmy PS, Kumar S, Mathew S, Assessment of pathological response of breast carcinoma in modified radical mastectomy specimens after neoadjuvant chemotherapy Int J Breast Cancer 2015 2015:53614510.1155/2015/53614526697228  [Google Scholar]  [CrossRef]  [PubMed]

[6]Sethi D, Sen R, Parshad S, Khetarpal S, Garg M, Sen J, Histopathologic changes following neoadjuvant chemotherapy in various malignancies Int J Appl Basic Med Res 2012 2:111-16.10.4103/2229-516X.10635323776823  [Google Scholar]  [CrossRef]  [PubMed]

[7]Carey LA, Metzger R, Dees EC, Collichio F, Sartor CI, Ollila DW, American Joint Committee on cancer tumour-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome J Natl Cancer Inst 2005 97:1137-42.10.1093/jnci/dji20616077072  [Google Scholar]  [CrossRef]  [PubMed]

[8]Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M, Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute J ClinOncol 1998 16:93-100.10.1200/JCO.1998.16.1.939440728  [Google Scholar]  [CrossRef]  [PubMed]

[9]Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Longterm outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival Ann Surg 2002 236:295-302.10.1097/00000658-200209000-0000612192316  [Google Scholar]  [CrossRef]  [PubMed]

[10]Herrada J, Iyer RB, Atkinson E N, Sneige N, Buzdar AU, Hortobagyi GN, Relative value of physical examination, mammography and breast sonography in evaluating the size of primary tumour and regional node metastasis in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma Clin Cancer Res 1997 3:1565-69.  [Google Scholar]

[11]Dershaw DD, Drossman S, Liberman L, Abramson A, Assessment of response to therapy of primary breast cancer by mammography and physical examination Cancer 1995 75:2093-98.10.1002/1097-0142(19950415)75:8<2093::AID-CNCR2820750811>3.0.CO;2-2  [Google Scholar]  [CrossRef]

[12]Honkoopl AH, van Diest PJ, de Jong JS, Linn SC, Gianccone G, Hoekman K, Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer Br J of Cancer 1998 77:621-26.10.1038/bjc.1998.999484820  [Google Scholar]  [CrossRef]  [PubMed]

[13]Davis AM, Bell RS, Goodwin PJ, Prognostic factors in osteosarcoma: a critical review J ClinOncol 1994 12:423-431.10.1200/JCO.1994.12.2.4238113851  [Google Scholar]  [CrossRef]  [PubMed]

[14]Gazet JC, Coombes RC, Ford HT, Griffin M, Corbishley C, Makinde V, Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer Br J Cancer 1996 73:758-62.10.1038/bjc.1996.1328611376  [Google Scholar]  [CrossRef]  [PubMed]

[15]Rasbridge SC, Gillett CE, Seymour AM, Patel K, Richards MA, Rubens RD, The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma Br J Cancer 1994 70:335-41.10.1038/bjc.1994.3037914426  [Google Scholar]  [CrossRef]  [PubMed]

[16]Aktepe F, Kapucuoglu N, Pak I, The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer Histopathology 1996 29:63-67.10.1046/j.1365-2559.1996.d01-485.x8818696  [Google Scholar]  [CrossRef]  [PubMed]